These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33711097)

  • 41. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition.
    Sakamoto K; Imamura T; Osone S; Nishimura A; Nishida M; Ishida H; Hosoi H
    Pediatr Transplant; 2015 Jun; 19(4):E97-100. PubMed ID: 25735190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eculizumab and thrombotic microangiopathy after hematopoietic stem cell transplantation: A report on its efficacy and safety in two pediatric patients.
    Genere L; Bacchetta J; Bertrand Y; Javouhey E; Cheikh N; Sellier-Leclerc AL
    Arch Pediatr; 2018 Nov; 25(8):485-488. PubMed ID: 30340942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
    Vasko R; Groenewold F; Korsten P; Müller GA; Koziolek M
    Ther Apher Dial; 2011 Oct; 15(5):507-9. PubMed ID: 21974708
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of severe systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis].
    Giebel S; Zoń-Giebel A; Błach A; Kucharz EJ; Hołowiecki J
    Pol Arch Med Wewn; 2003 Aug; 110(2):891-7. PubMed ID: 14682229
    [No Abstract]   [Full Text] [Related]  

  • 46. [Advances in the diagnosis and management of transplant-associated thrombotic microangiopathy].
    Yang LP; Liu X; Zhang XH
    Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):693-699. PubMed ID: 34547882
    [No Abstract]   [Full Text] [Related]  

  • 47. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis.
    Martini A; Maccario R; Ravelli A; Montagna D; De Benedetti F; Bonetti F; Viola S; Zecca M; Perotti C; Locatelli F
    Arthritis Rheum; 1999 Apr; 42(4):807-11. PubMed ID: 10211898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?
    Loh Y; Oyama Y; Statkute L; Verda L; Quigley K; Yaung K; Barr W; Jovanovic B; Burt RK
    Bone Marrow Transplant; 2007 Apr; 39(7):435-7. PubMed ID: 17310133
    [No Abstract]   [Full Text] [Related]  

  • 49. Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients.
    Michel L; Farge D; Baraut J; Marjanovic Z; Jean-Louis F; Porcher R; Grigore EI; Deligny C; Romijn F; Arruda LC; van Pelt J; Levarht N; Verrecchia F; van Laar JM
    Bone Marrow Transplant; 2016 Aug; 51(8):1146-9. PubMed ID: 27042845
    [No Abstract]   [Full Text] [Related]  

  • 50. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
    Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E;
    Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
    Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
    Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis.
    van Laar JM; Farge D; Tyndall A
    Ann Rheum Dis; 2005 Oct; 64(10):1515. PubMed ID: 16162905
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy.
    Martínez-Muñoz ME; Forés R; Lario A; Bautista G; Bueno JL; de Miguel C; Navarro B; De Laiglesia A; Sánchez-Guerrero A; Cabrera JR; Duarte RF
    Bone Marrow Transplant; 2019 Jan; 54(1):142-145. PubMed ID: 29899573
    [No Abstract]   [Full Text] [Related]  

  • 54. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombotic Microangiopathy in Cancer.
    Weitz IC
    Semin Thromb Hemost; 2019 Jun; 45(4):348-353. PubMed ID: 31041804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
    Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
    Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stem cell transplantation in systemic sclerosis.
    van Laar JM; Sullivan K
    Curr Opin Rheumatol; 2013 Nov; 25(6):719-25. PubMed ID: 24047607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.
    Helbig G; Widuchowska M; Koclęga A; Kopińska A; Kopeć-Mędrek M; Gaweł WB; Spałek A; Żak J; Grygoruk-Wiśniowska I; Liwoch R; Kucharz E; Markiewicz M
    Clin Rheumatol; 2018 Jun; 37(6):1709-1714. PubMed ID: 29256111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
    Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
    Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
    Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.